Karin Innes
Karin Innes
Senior Associate


Level 23, 200 Queen St
Melbourne VIC 3000 AUSTRALIA
Tel +61 3 8618 4118
Fax +61 3 8618 4199
Recent Publications
22 Sep 2011
On Friday 16 September 2011, President Obama signed into law the Leahy-Smith America Invents Act (AIA) which makes significant changes to US Patent law.

01 Dec 2010
On 26 November 2010, the report of the Senate Community Affairs References Committee (the Committee) relating to the patenting of human genes and genetic materials was released. At over 170 pages, the report is lengthy reading however, the substance of the report can be distilled down to 16 recommendations, the more pertinent of which are discussed in this article.

30 Nov 2010
Seemingly unhappy with the Recommendations resulting from the Senate Inquiry into Gene Patents, a number of Senators, including Helen Coonan, Bill Heffernan, Rachel Siewert and Nick Xenophon, have introduced a Private Members Bill into the Federal Parliament.
Karin is a qualified patent and trade mark attorney and Senior Associate with FB Rice.  She registered as a patent attorney in 2002 and joined the firm in 2007 after working for the patent attorney practices in two large Australian law firms.
 
Karin practices in the preparation and prosecution of patent applications before the Australian and New Zealand Patent Offices. She also manages international patent portfolios and regularly conducts patentability, infringement, due diligence and freedom to operate analysis.  Karin has also been involved in contentious patent matters including patent oppositions and litigation matters, including conducting discovery and acting in a technical advisory capacity to brief barristers.  Her clients range from universities and academic research institutes to start-ups and large biotechnology companies.
 
Karin has a particular interest in stem cell biology.  Her PhD research which was undertaken at the prestigious Walter and Eliza Hall Institute for Medical Research focussed on strategies to generate immortalised murine haemopoietic stem cells.  Following her PhD, Karin worked in clinical research for Amgen Australia where she managed phase I, II and III clinical trials in the oncology area.
 
Karin has published papers in both the scientific and legal media.
 

Education

  • BSc (Hons) from the University of Melbourne, with a double major in microbiology and biochemistry
  • PhD from Walter and Eliza Hall Institute for Medical Research focusing on the use of oncogenes to generate immortal murine stem cell lines

Key Areas of Expertise

  • Stem cells
  • Cell biology
  • Immunology
  • Gene silencing
  • Microbiology

Industry Focus

Professional Affiliations
  • Fellow of the Institute of Patent and Trade Mark Attorneys of Australia
  • Member of the Intellectual Property Society of Australia and New Zealand
Copyright 2010 - 2011 FB Rice, All rights reserved